Perimeter Medical Imaging
Privately held medical device company.
| CAD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 1496 % | 204 % | 110 % | 285 % | 116 % | 115 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (140655 %) | (11539 %) | (3697 %) | (2089 %) | (517 %) | (230 %) | (48 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (146802 %) | (7461 %) | (3478 %) | (1583 %) | (587 %) | (244 %) | (43 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 39665 % | 4125 % | 1277 % | 785 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Perimeter Medical Imaging AI, Inc. is a healthcare technology company specializing in advanced imaging solutions for tissue visualization and assessment. The company operates in the medical imaging market, primarily serving healthcare providers, including hospitals and clinics, that require precise imaging for excised tissue, biopsy assessment, and tissue viability for transplantation. Perimeter's core product, the OTIS Wide-field Optical Coherence Tomography (OCT) platform, offers high-resolution subsurface image volumes of intact excised tissue, automated full specimen scanning, and intraoperative imaging capabilities.
Perimeter's business model revolves around selling its imaging systems and associated software to medical institutions, generating revenue through direct sales and service contracts. The company also leverages artificial intelligence to enhance the accuracy and efficiency of its imaging solutions, providing a competitive edge in the market.
Perimeter Medical Imaging AI aims to improve clinical outcomes by offering innovative tools that assist in the accurate assessment of tissue samples, ultimately contributing to better patient care.
Keywords: medical imaging, tissue visualization, OCT platform, healthcare technology, biopsy assessment, tissue viability, transplantation, AI-enhanced imaging, clinical applications, healthcare providers.